Vaccines and Public Health | Johns Hopkins | Bloomberg School of Public Health

covid vaccine vials, syringes, and bandaids on a metal tray

What to Know About the Updated COVID Vaccine for Fall, Winter 2024–25

August 25, 2024

The updated COVID vaccine provides safe, effective protection against current variants for everyone 6 months and older.

COVID-19

Infectious Diseases

Vaccines

Bloomberg School

A health worker administers oral cholera vaccine to a child in Zambia.

Study Finds Single-Dose Cholera Vaccine as Effective as Standard Two-Dose Regimen in Cholera Endemic Setting

January 19, 2024

Vaccines

Department of Epidemiology

What to Know About JN.1, the Latest Omicron Variant

January 09, 2024

JN.1 is now the dominant variant in the U.S., causing over 60% of COVID cases. The good news: Vaccines, tests, and antivirals are effective against it.

COVID-19

Infectious Diseases

Vaccines

Bloomberg School

a collage of various scientific advances

Progress in Public Health: The 2023 Highlights

December 21, 2023

Public health year in review: 2023 was a mixed bag, but there is major progress worth celebrating.

Bloomberg School

Two New RSV Products to Protect Infants

November 13, 2023

A new vaccine for pregnant people and an antibody treatment for babies could substantially lower the rates of severe RSV infections among children.

Infectious Diseases

Vaccines

Child and Adolescent Health

Bloomberg School

Employees work on the production line of N95 facemasks at a factory on December 8, 2022 in Xuchang, Henan Province of China. Niu Shupei/VCG via Getty Images

We Know How to Prevent the Next Pandemic—But It’s Easier Said Than Done

October 27, 2023

Why does pandemic preparedness remain elusive, even when the path to achieving it is well-understood?

Global Health NOW

Vaccines Faculty Experts

Looking for prominent public health experts in the field of vaccines? They’re here at the Bloomberg School of Public Health.

William John Moss

Professor

Epidemiology

Anna P. Durbin

Professor

International Health

Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.

Daniel Salmon

Professor

International Health

Daniel Salmon, PhD ’03, MPH, is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making.

Ruth Karron

Professor

International Health

Vaccines

Vaccines Headlines

What to Know About the Updated COVID Vaccine for Fall, Winter 2024–25

Study Finds Single-Dose Cholera Vaccine as Effective as Standard Two-Dose Regimen in Cholera Endemic Setting

What to Know About JN.1, the Latest Omicron Variant

Progress in Public Health: The 2023 Highlights

Two New RSV Products to Protect Infants

We Know How to Prevent the Next Pandemic—But It’s Easier Said Than Done

Vaccines Faculty Experts

William John Moss

Anna P. Durbin

Daniel Salmon

Ruth Karron

Departments

Programs

Centers & Institutes

Upcoming Events

Pop-up Mentoring: Hyungwoo Kim, vaccine science and policy expert

The Battle to Beat Malaria: Current Status and Future Prospects for Malaria Vaccines